SEC Form 4 · accession 0001140361-17-024504
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elaine J Heron
Director
Period of report
Jun 6, 2017
Accepted (ET)
Jun 8, 2017 · 6:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 6, 2017 | A | 2,050 | $0.00 | A | 39,185 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Common StockF2 | $89.60 | Jun 6, 2017 | A | 4,910 | A | Jun 6, 2018 | Jun 5, 2027 | Common Stock | 4,910 | 4,910 | D |
Explanation of responses
- F1Restricted stock units granted on June 6, 2017. Price not applicable.
- F2Option grant vests in full on June 6, 2018.